Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|November 5, 2015
The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling PathwaysZaklina Kovacevic, Sharleen V Menezes, Sumit Sahni, et al.
The Journal of Biological Chemistry|February 18, 2014
The metastasis suppressor, N-myc downstream-regulated gene 1 (NDRG1), inhibits stress-induced autophagy in cancer cellsSumit Sahni, Dong-Hun Bae, Darius J R Lane, et al.
Biochimica Et Biophysica Acta. General Subjects|July 15, 2020
PSMD11, PTPRM and PTPRB as novel biomarkers of pancreatic cancer progressionSumit Sahni, Christoph Krisp, Mark P Molloy, et al.
Advanced Drug Delivery Reviews|July 11, 2025
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategiesTaymin du Toit-Thompson, Lionel Leck, Josef Gillson, et al.
Journal of Clinical Pathology|June 11, 2013
The role of NDRG1 in the pathology and potential treatment of human cancersDong-Hun Bae, Patric J Jansson, Michael L Huang, et al.
The Journal of Biological Chemistry|January 22, 2022
Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1Bekesho Geleta, Faten S Tout, Syer Choon Lim, et al.
International Journal of Molecular Sciences|November 18, 2016
Letter to the Editor: "Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques"Angelica M Merlot, Sumit Sahni, Darius J R Lane, et al.
European Journal of Medicinal Chemistry|August 26, 2017
A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer's diseaseDuraippandi Palanimuthu, Rachal Poon, Sumit Sahni, et al.
Cancer Science|March 4, 2024
Serum and tissue metallome of pancreatic ductal adenocarcinomaSooin Byeon, Taymin du Toit-Thompson, Luke Hipperson, et al.
European Journal of Clinical Investigation|April 8, 2025
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgerySooin Byeon, Bridget Abbott, Paul Roach, et al.
Pageof 9